GOT1 and delirium: Several trials reported adverse effects in the acyclovir arm such as rise in hepatic transaminases Serum glutamic oxaloacetic transaminase (SGOT) and Serum glutamic pyruvic transaminase (SGPT), rash, nephrotoxicity and delirium.